A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

2013 ◽  
Vol 2013 ◽  
pp. 79-80
Author(s):  
J.A. Stockman
Sign in / Sign up

Export Citation Format

Share Document